Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease.
Krackhardt F, Waliszewski M, Kočka V, Toušek P, Janek B, Hudec M, Lozano F, Roman KG, Del Blanco BG, Mauri J, Heang TM, Ahn TH, Jeong MH, Herberger D, Tomulic V, Levy G, Sebagh L, Rischner J, Pansieri M. Krackhardt F, et al. Among authors: heang tm. Cardiovasc Drugs Ther. 2020 Jun;34(3):335-344. doi: 10.1007/s10557-020-06963-5. Cardiovasc Drugs Ther. 2020. PMID: 32212061 Free PMC article.
Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.
Krackhardt F, Rosli MA, Leschke M, Schneider A, Sperling C, Heang TM, Pons M, Sousa PJ, Kherad B, Waliszewski M. Krackhardt F, et al. Among authors: heang tm. Catheter Cardiovasc Interv. 2018 Jun;91(7):1221-1228. doi: 10.1002/ccd.27306. Epub 2017 Sep 25. Catheter Cardiovasc Interv. 2018. PMID: 28944613
Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice.
Krackhardt F, Kočka V, Waliszewski M, Toušek P, Janek B, Trenčan M, Krajči P, Lozano F, Roman KG, Otaegui I, Del Blanco BG, Del Olmo VV, Nofrerías EF, Wachowiak L, Heang TM, Ahn TH, Jeong MH, Jung BC, Han KR, Piot C, Sebagh L, Rischner J, Pansieri M, Leschke M. Krackhardt F, et al. Among authors: heang tm. Medicine (Baltimore). 2020 Feb;99(8):e19119. doi: 10.1097/MD.0000000000019119. Medicine (Baltimore). 2020. PMID: 32080086 Free PMC article. Clinical Trial.
Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry.
Cortese B, Testa L, Di Palma G, Heang TM, Bossi I, Nuruddin AA, Ielasi A, Tespili M, Perez IS, Milazzo D, Benincasa S, Latib A, Cacucci M, Caiazzo G, Seresini G, Tomai F, Ocaranza R, Torres A, Perotto A, Bedogni F, Colombo A. Cortese B, et al. Among authors: heang tm. J Cardiovasc Med (Hagerstown). 2021 Feb 1;22(2):94-100. doi: 10.2459/JCM.0000000000001070. J Cardiovasc Med (Hagerstown). 2021. PMID: 32740442
Correction to: Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease.
Krackhardt F, Waliszewski M, Kočka V, Toušek P, Janek B, Hudec M, Lozano F, Roman KG, Del Blanco BG, Mauri J, Heang TM, Ahn TH, Jeong MH, Herberger D, Tomulic V, Levy G, Sebagh L, Rischner J, Pansieri M. Krackhardt F, et al. Among authors: heang tm. Cardiovasc Drugs Ther. 2022 Dec;36(6):1257-1258. doi: 10.1007/s10557-021-07290-z. Cardiovasc Drugs Ther. 2022. PMID: 35867320 Free PMC article. No abstract available.
Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry.
Cortese B, Testa L, Heang TM, Ielasi A, Bossi I, Latini RA, Lee CY, Perez IS, Milazzo D, Caiazzo G, Tomai F, Benincasa S, Nuruddin AA, Stefanini G, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Sciahbasi A, Ocaranza R, Menown IBA, Torres A, Sengottvelu G, Zanetti A, Pesenti N, Colombo A; EASTBOURNE Investigators. Cortese B, et al. Among authors: heang tm. JACC Cardiovasc Interv. 2023 Jul 24;16(14):1794-1803. doi: 10.1016/j.jcin.2023.05.005. JACC Cardiovasc Interv. 2023. PMID: 37495352 Free article.
Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registry.
Mangier A, Testa L, Heang TM, Bossi I, Lee CY, Perez IS, Milazzo D, Nuruddin AA, Seresini G, Singh R, Cacucci M, Sciahbasi A, Torres A, Sengottvelu G, Colombo A, Cortese B; EASTBOURNE investigators. Mangier A, et al. Among authors: heang tm. Cardiovasc Revasc Med. 2024 Jul 30:S1553-8389(24)00610-9. doi: 10.1016/j.carrev.2024.07.024. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39191613
Two-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease: the EASTBOURNE Registry.
Leone PP, Heang TM, Yan LC, Perez IS, Caiazzo G, Geraci S, Jiyen K, Tomai F, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Ocaranza R, Torres A, Caruso M, Azzalini L, Pesenti N, Colombo A, Cortese B, Investigators OBOTE. Leone PP, et al. Among authors: heang tm. EuroIntervention. 2024 Jul 1;20(13):e831-e833. doi: 10.4244/EIJ-D-23-00966. EuroIntervention. 2024. PMID: 38949239 Free article. No abstract available.
Long term clinical outcome of sirolimus drug coated balloons in large coronary vessels.
Sciahbasi A, Salvi N, Heang TM, Perez IS, Geraci S, Vaccaro G, Benincasa S, Nuruddin AA, Ocaranza R, Giannini F, Greco A, Cortese B. Sciahbasi A, et al. Among authors: heang tm. Catheter Cardiovasc Interv. 2024 Mar;103(4):532-538. doi: 10.1002/ccd.30996. Epub 2024 Feb 28. Catheter Cardiovasc Interv. 2024. PMID: 38415895
11 results